Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,632.19
(
0.00%
)
US TECH 100
24,008.80
(
1.09%
)
Dow Jones
46,558.47
(
0.00%
)
Brent Oil
99.76
(
-1.45%
)
Bitcoin
73,815.22
(
1.38%
)
News Focus
News Focus
Post# of 257244
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: genisi post# 113722

Monday, 01/31/2011 1:27:45 PM

Monday, January 31, 2011 1:27:45 PM

Post# of 257244
>>MAPP/Allergan

Can anyone think of other examples where there has been a similar split with the drug developer retaining primary care and licensing out the specialty segment (here pain/neurologists)?

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now